2023
DOI: 10.1016/j.bbrc.2023.05.092
|View full text |Cite
|
Sign up to set email alerts
|

Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…123 Conversely, REV-ERBα agonists suppress TGF-β1 (transforming growth factor β1)-induced fibroblast-tomyofibroblast transition and profibrotic phenotype. 124,125 Consistent with the knowledge that the CLOCK/BMAL1 heterodimer is immediately upstream of REV-ERBα, mice deficient for BMAL1 in the proximal tubule exhibit increased renal fibrosis in response to stress. 126 Collectively, these observations highlight that critical fibroblast functions are under circadian control.…”
Section: Compendium: Circadian Mechanisms In Cardio/ Cerebrovascular ...mentioning
confidence: 69%
“…123 Conversely, REV-ERBα agonists suppress TGF-β1 (transforming growth factor β1)-induced fibroblast-tomyofibroblast transition and profibrotic phenotype. 124,125 Consistent with the knowledge that the CLOCK/BMAL1 heterodimer is immediately upstream of REV-ERBα, mice deficient for BMAL1 in the proximal tubule exhibit increased renal fibrosis in response to stress. 126 Collectively, these observations highlight that critical fibroblast functions are under circadian control.…”
Section: Compendium: Circadian Mechanisms In Cardio/ Cerebrovascular ...mentioning
confidence: 69%
“…In a mouse model of bleomycin-induced pulmonary fibrosis, it was observed that the REV-ERBα protein, involved in circadian cycle regulation, inhibited the fibrotic response triggered by TGFβ. Conversely, the suppression of REV-ERBα promoted fibroblastto-myofibroblast (FTM) differentiation, driving fibrosis [126], while REV-ERBα agonists prevented TGFβ-induced FTM, reduced the IL-6 levels, and reduced the expression of extracellular matrix (ECM) genes [127]. In mice, bleomycin exposure lowered the REV-ERBα levels, which was reverted with a REV-ERBα agonist (SR9009), and prevented collagen overexpression, while influenza A virus (IAV) infection increased the collagen and lysyl oxidase levels, which was prevented by a REV-ERBα agonist (GSK4112) [128].…”
Section: Idiopathic Pulmonary Fibrosismentioning
confidence: 99%